MedTrace Logo

Oral Acetaminophen Use for Pain Reduction in Electrophysiology Procedures

NCT03702023 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-07-02

No results posted yet for this study

Summary

The investigators are purposing a study to evaluate the use of acetaminophen given prior to an electrophysiology procedure and post procedural pain control.

Conditions

  • Post Electrophysiology Procedure Pain

Interventions

DRUG

Acetaminophen

Intervention group will receive 1000 mg of acetaminophen

DRUG

Placebo Oral Tablet

Control group will be given a placebo capsule.

Sponsors & Collaborators

  • Ascension Health

    lead INDUSTRY

Principal Investigators

  • Michael Taipale, D.O. · Ascension Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2020-06-01
Completion
2020-06-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03702023 on ClinicalTrials.gov